CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 52 filers reported holding CORVUS PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $2,528,000 | -18.4% | 121,715 | -43.8% | 0.32% | -48.4% |
| Q4 2016 | $3,098,000 | -29.8% | 216,619 | -19.3% | 0.63% | -19.2% |
| Q3 2016 | $4,415,000 | +313.8% | 268,369 | +258.8% | 0.78% | +227.0% |
| Q2 2016 | $1,067,000 | -1.7% | 74,800 | 0.0% | 0.24% | -37.5% |
| Q1 2016 | $1,085,000 | – | 74,800 | – | 0.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 3,101,709 | $7,475,000 | 1.50% |
| ADAMS STREET PARTNERS LLC | 3,275,616 | $7,894,000 | 1.20% |
| Telemetry Investments, L.L.C. | 192,909 | $465,000 | 0.60% |
| CHI Advisors LLC | 400,000 | $964,000 | 0.32% |
| Orbimed Advisors | 6,943,654 | $16,734,000 | 0.22% |
| Ikarian Capital, LLC | 482,610 | $1,163,000 | 0.17% |
| Anson Funds Management LP | 528,358 | $1,273,000 | 0.12% |
| BVF INC/IL | 1,370,947 | $3,304,000 | 0.12% |
| VR Adviser, LLC | 250,000 | $603,000 | 0.08% |
| PURA VIDA INVESTMENTS, LLC | 492,384 | $1,187,000 | 0.04% |